Pharmaceuticals

Forum Session — July 22, 2010
Focus on Reform: How a Law Becomes a Reg - Regulatory Processes to Implement Legislation
Author: Judith D. Moore

Forum Session — July 16, 2010
Focus on Reform: Health Care Safety Net-Related Provisions
Author: Jessamy Taylor

Forum Session — March 12, 2010
Not Your Father's Drug Approval Process: FDAAA and the Evolving Pharmaceutical Marketplace
Author: Michele J. Orza, ScD

The Basics — March 10, 2010
The Ryan White HIV/AIDS Program
Author: Jessamy Taylor

Forum Session — December 11, 2009
Conflicts of Interest in Medicine II: Issues Surrounding Industry Funding of Physician Education
Author: Michele J. Orza, ScD

Forum Session — October 30, 2009
Prevention and Early Detection of Health Care Fraud, Abuse, and Waste
Author: Mary Ellen Stahlman

Background Paper No. 70 — August 31, 2009
Coverage and Payment for Prescription Drugs Under Medicare Part B: A Complex Patchwork
Author: Amanda Cassidy, Consultant

Issue Brief No. 833 — July 31, 2009
The Medicare Drug Benefit: Update on the Low-Income Subsidy
Author: Mary Ellen Stahlman

Forum Session — May 15, 2009
Conflicts of Interest in Medicine: What's the Problem?
Author: Michele J. Orza, ScD

The Basics — April 13, 2009
The Medicaid Drug Rebate Program
Author: Christie Provost Peters

Fundamentals Briefing — January 30, 2009
The World of Prescription Drugs: Approvals, Pricing, and Purchasing
Authors: Laura A. Dummit & Mary Ellen Stahlman

Background Paper — January 28, 2008
Pharmacogenomics: A Primer for Policymakers
Author: Leslie Tucker, Consultant

Background Paper — May 9, 2007
The Prescription Drug Safety Net: Access to Pharmaceuticals for the Uninsured
Author: Jack Hoadley, PhD

Meeting Report — December 6, 2006
A Report from the Forum Session "Complexity, Coordination and Compromise: States and the Medicare Drug Benefit" (August 4, 2006)
Author: Lee Partridge, Consultant

Forum Session — August 4, 2006
Complexity, Coordination and Compromise: States and the Medicare Drug Benefit
Authors: Judith D. Moore & Jennifer Ryan

Forum Session — March 14, 2006
Caring for “Ryan White”: Balancing Quality, Access, Equity, and Finite Resources
Author: Jessamy Taylor

Background Paper — January 25, 2006
The Vaccine Industry: Does It Need a Shot in the Arm?
Authors: Eileen Salinsky & Cole Werble, Consultant

Meeting Report — September 22, 2005
A Report from the Forum Session “Implementing the Medicare Prescription Drug Benefit: Continuing Challenges for States”
Author: Lee Partridge, Consultant

Issue Brief No. 807 — August 29, 2005
One Pill, Many Prices: Variation in Prescription Drug Prices in Selected Government Programs
Author: Dawn M. Gencarelli

Background Paper — August 22, 2005
Caring for "Ryan White": The Fundamentals of HIV/AIDS Treatment Policy
Author: Jessamy Taylor

Forum Session — July 12, 2005
Implementing the New Medicare Drug Benefit: Continuing Challenges For States
Author: Judith D. Moore

Forum Session — June 10, 2005
How Will They Know? Where Will They Go? Education and Outreach for the Medicare Drug Benefit
Author: Judith D. Moore

Forum Session — December 1, 2004
Implementing the Formulary Requirements Under the New Medicare Prescription Drug Benefit
Author: Dawn M. Gencarelli

Forum Session — November 8, 2004
Influenza Vaccine Shortages: Dress Rehearsal for a Future Pandemic? Or Wake-Up Call?
Author: Eileen Salinsky

Meeting Report — August 31, 2004
A Report from the Forum Session “Implementing the New Medicare Drug Benefit: Challenges and Opportunities for States”
Authors: Judith D. Moore & Jennifer Ryan

Background Paper — August 27, 2004
Tick-Tock: Preparing for the Next Influenza Pandemic
Author: Eileen Salinsky

Background Paper — August 24, 2004
Fundamentals of the Prescription Drug Market
Author: Christie Provost Peters

Forum Session — July 22, 2004
Implementing the New Medicare Drug Benefit: Challenges and Opportunities for States
Authors: Judith D. Moore & Jennifer Ryan

Forum Session — June 9, 2004
The Economics of Prescription Drug Importation
Author: Dawn M. Gencarelli

The Basics — April 26, 2004
State Pharmacy Assistance Programs
Author: Jennifer Ryan

Forum Session — February 6, 2004
Evidence- and Value-Based Approaches to Drug Formularies: What Role Will They Play in the Medicare Prescription Drug Benefit?
Author: Dawn M. Gencarelli

The Basics — February 4, 2004
Prescription Drug Formularies
Author: Dawn M. Gencarelli

Forum Session — June 17, 2003
Medicaid Prescription Drug Coverage: State Efforts to Control Costs
Author: Dawn M. Gencarelli

Issue Brief No. 790 — May 10, 2003
Medicaid Prescription Drug Coverage: State Efforts to Control Costs
Author: Dawn M. Gencarelli

Small-Group Session — April 4, 2003
Who Will Pay for the Adverse Events Resulting from Smallpox Vaccination? Liability and Compensation Issues
Author: Eileen Salinsky

Issue Brief No. 788 — March 12, 2003
Who Will Pay for the Adverse Events Resulting from Smallpox Vaccination? Liability and Compensation Issues
Authors: Robin J. Strongin, Consultant & Eileen Salinsky

Forum Session — November 19, 2002
Pharmacy Plus Waivers: Incrementalism at Work
Author: Jennifer Ryan

Issue Brief No. 785 — November 15, 2002
U.S. Childhood Vaccine Availability: Legal, Regulatory, and Economic Complexities
Author: Robin J. Strongin, Consultant

Issue Brief No. 784 — November 12, 2002
Prescription Drugs in Nursing Homes: Managing Costs and Quality in a Complex Environment
Authors: Dan Mendelson, Rajeev Ramchand, Richard Abramson, MD & Anne Tumlinson, Consultants

Forum Session — July 12, 2002
Average Wholesale Price for Prescription Drugs: Is There a More Appropriate Pricing Mechanism?
Author: Dawn M. Gencarelli

Background Paper — June 21, 2002
Hatch-Waxman, Generics, and Patents: Balancing Prescription Drug Innovation, Competition, and Affordability
Author: Robin J. Strongin, Consultant

Issue Brief No. 775 — June 7, 2002
Average Wholesale Price for Prescription Drugs: Is There a More Appropriate Pricing Mechanism?
Author: Dawn M. Gencarelli

Site Visit — April 19, 2002
Food and Drug Administration: Center for Biologics Evaluation and Research (Bethesda, Maryland)
Author: Robin J. Strongin, Consultant

Site Visit — October 12, 2001
Food and Drug Administration, Center for Drug Evaluation and Research
Author: Robin J. Strongin, Consultant

Issue Brief No. 762 — April 25, 2001
State-Based Pharmaceutical Assistance Programs: Temporary Fix or Lessons for Medicare?
Author: Robin J. Strongin, Consultant

Forum Session — April 25, 2001
State-Based Pharmaceutical Assistance Programs: Temporary Fix or Lessons for Medicare?
Author: Robin J. Strongin, Consultant

Forum Session — September 15, 2000
ASPE's Conference on Pharmaceutical Pricing Practices, Utilization, and Costs: A Recap and Some Further Thoughts
Author: Robin J. Strongin

Issue Brief No. 755 — May 31, 2000
Pharmaceutical Marketplace Dynamics
Author: Robin J. Strongin

Forum Session — May 31, 2000
Pharmaceutical Marketplace Dynamics
Author: Robin J. Strongin

Forum Session — March 31, 2000
Designing a Medicare Prescription Drug Benefit: Safety and Structure Considerations
Author: Robin J. Strongin

Forum Session — March 10, 2000
Beyond Survey Data: Prescription Drugs, Medicare, and Managed Care
Author: Robin J. Strongin

Issue Brief No. 751 — January 7, 2000
Reshaping AHCs' Role in Biomedical Research
Author: Karen Matherlee

Forum Session — January 7, 2000
Reshaping AHCs' Role in Biomedical Research
Author: Karen Matherlee

Background Paper — November 1999
The Public Stake in Biomedical Research: A Policy Perspective
Author: Karen Matherlee

Forum Session — April 8, 1999
Providing Outpatient Prescription Drugs through Medicare: Can We Afford To? Can We Afford Not To?
Author: Robin J. Strongin

Background Paper — March 1999
Providing Outpatient Prescription Drugs through Medicare: Can We Afford To? Can We Afford Not To?
Author: Robin J. Strongin

Issue Brief No. 722 — July 9, 1998
Medicare Coverage and Technology Diffusion: Past, Present, and Future
Author: Robin J. Strongin

Forum Session — July 9, 1998
Medicare Coverage and Technology Diffusion: Past, Present, and Future
Author: Robin J. Strongin